Calcitriol oral therapy for the prevention of secondary hyperparathyroidism in patients with predialytic renal failure

scientific article published on 01 April 1998

Calcitriol oral therapy for the prevention of secondary hyperparathyroidism in patients with predialytic renal failure is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID9582556

P2093author name stringFerdeghini M
Panichi V
Giovannini L
Migliori M
Palla R
Taccola D
De Pietro S
Andreini B
P433issue4
P921main subjectsecondary hyperparathyroidismQ3622611
P304page(s)245-250
P577publication date1998-04-01
P1433published inClinical NephrologyQ15763520
P1476titleCalcitriol oral therapy for the prevention of secondary hyperparathyroidism in patients with predialytic renal failure
P478volume49

Reverse relations

cites work (P2860)
Q84978295Evidence-based practice guideline for the treatment of CKD
Q81241879Intermittent or daily administration of 1-alpha calcidol for nephrectomised infants on peritoneal dialysis?
Q33610289Treatment options of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease stages 3 and 4: an historic review
Q33818722Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease

Search more.